BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21060881)

  • 1. Antiangiogenic activity of 2-deoxy-D-glucose.
    Merchan JR; Kovács K; Railsback JW; Kurtoglu M; Jing Y; Piña Y; Gao N; Murray TG; Lehrman MA; Lampidis TJ
    PLoS One; 2010 Oct; 5(10):e13699. PubMed ID: 21060881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis.
    Singh S; Pandey S; Chawla AS; Bhatt AN; Roy BG; Saluja D; Dwarakanath BS
    Eur J Cancer; 2019 Dec; 123():11-24. PubMed ID: 31670076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
    DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
    Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.
    Kovács K; Decatur C; Toro M; Pham DG; Liu H; Jing Y; Murray TG; Lampidis TJ; Merchan JR
    Mol Cancer Ther; 2016 Feb; 15(2):264-75. PubMed ID: 26637370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
    Kurtoglu M; Gao N; Shang J; Maher JC; Lehrman MA; Wangpaichitr M; Savaraj N; Lane AN; Lampidis TJ
    Mol Cancer Ther; 2007 Nov; 6(11):3049-58. PubMed ID: 18025288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
    Liu H; Kurtoglu M; Cao Y; Xi H; Kumar R; Axten JM; Lampidis TJ
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):251-62. PubMed ID: 23700291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.
    Berthe A; Zaffino M; Muller C; Foulquier F; Houdou M; Schulz C; Bost F; De Fay E; Mazerbourg S; Flament S
    Breast Cancer Res Treat; 2018 Oct; 171(3):581-591. PubMed ID: 29971627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.
    Pajak B; Siwiak E; Sołtyka M; Priebe A; Zieliński R; Fokt I; Ziemniak M; Jaśkiewicz A; Borowski R; Domoradzki T; Priebe W
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2-deoxyglucose inhibits angiogenesis of rheumatoid arthritis via activating AMPK pathway].
    Wang Y; Wei Y; Cheng X; Sun X; Ma L; Song Y; Zhou J; Wei F; Liu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):962-968. PubMed ID: 30187877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.
    Piña Y; Houston SK; Murray TG; Koru-Sengul T; Decatur C; Scott WK; Nathanson L; Clarke J; Lampidis TJ
    Clin Ophthalmol; 2012; 6():817-30. PubMed ID: 22701083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.
    Pająk B; Zieliński R; Manning JT; Matejin S; Paessler S; Fokt I; Emmett MR; Priebe W
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype.
    O'Neill S; Porter RK; McNamee N; Martinez VG; O'Driscoll L
    Sci Rep; 2019 Mar; 9(1):3788. PubMed ID: 30846710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of T cell-mediated cytolysis by 2-deoxy-D-glucose:dissociation of the inhibitory effect from glycoprotein synthesis.
    MacDonald HR; Cerottini JC
    Eur J Immunol; 1979 Jun; 9(6):466-70. PubMed ID: 315316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
    Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
    Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation.
    Sun X; Fan T; Sun G; Zhou Y; Huang Y; Zhang N; Zhao L; Zhong R; Peng Y
    Biochem Pharmacol; 2022 May; 199():115029. PubMed ID: 35381210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
    Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.
    Singh S; Pandey S; Bhatt AN; Chaudhary R; Bhuria V; Kalra N; Soni R; Roy BG; Saluja D; Dwarakanath BS
    PLoS One; 2015; 10(7):e0132089. PubMed ID: 26135741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
    Kurtoglu M; Maher JC; Lampidis TJ
    Antioxid Redox Signal; 2007 Sep; 9(9):1383-90. PubMed ID: 17627467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2.
    Liu H; Jiang CC; Lavis CJ; Croft A; Dong L; Tseng HY; Yang F; Tay KH; Hersey P; Zhang XD
    Mol Cancer; 2009 Dec; 8():122. PubMed ID: 20003459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.